[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371598-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371598-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pro-apoptotic-activity-of-1-4567-tetrabromo-1h-benzimidazol-1-ylpropan-2-one-an-intracellular-inhibitor-of-pim-1-kinase-in-acute-lymphoblastic-leukemia-and-breast-cancer-cells","Pro-Apoptotic Activity of 1-(4,5,6,7-Tetrabromo-1H-benzimidazol-1-yl)propan-2-one - an Intracellular Inhibitor of PIM-1 Kinase in Acute Lymphoblastic Leukemia and Breast Cancer Cells","","Inhibition of CK2 and/or PIM-1 kinases has been shown to induce apoptosis across multiple cancer cell lines, positioning these enzymes as valuable anti-cancer targets. This study synthesizes a series of N-substituted derivatives of 4,5,6,7-tetrabromo-1H-benzimidazole and evaluates their anti-cancer potential. Enzymatic assays and in silico docking assess CK2α and PIM-1 inhibition, while cytotoxicity is measured by MTT. Apoptosis is quantified in the most responsive lines (CCRF-CEM and MCF-7) via annexin V binding, mitochondrial membrane potential disruption, caspase-3 activation, and cell cycle analysis. Intracellular CK2/PIM-1 inhibition is confirmed by Western blot and phospho-flow cytometry, revealing a novel TBBi derivative with strong pro-apoptotic activity and intracellular PIM-1 inhibition, supporting PIM-1 as a promising leukemia target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pro-apoptotic-activity-of-1-4567-tetrabromo-1h-benzimidazol-1-ylpropan-2-one-an-intracellular-inhibitor-of-pim-1-kinase-in-acute-lymphoblastic-leukemia-and-breast-cancer-cells/371598/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pro-apoptotic-activity-of-1-4567-tetrabromo-1h-benzimidazol-1-ylpropan-2-one-an-intracellular-inhibitor-of-pim-1-kinase-in-acute-lymphoblastic-leukemia-and-breast-cancer-cells/371598.png","ImageObject",300,407,{"name":42,"@type":43},"นรินทร์","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main goal of this study?","Question",{"text":63,"@type":64},"To synthesize N-substituted tetrabromo-benzimidazole derivatives and evaluate whether they can induce apoptosis by inhibiting CK2 and/or PIM-1, including intracellular PIM-1 inhibition.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were kinase inhibition and anti-cancer activity assessed?",{"text":68,"@type":64},"CK2α and PIM-1 inhibition were measured by enzymatic assays and supported by in silico docking; anti-cancer effects were evaluated using MTT cytotoxicity assays in cancer cell lines.",{"name":70,"@type":61,"acceptedAnswer":71},"Which assays were used to confirm apoptosis induction?",{"text":72,"@type":64},"In the most responsive lines (CCRF-CEM and MCF-7), apoptosis was analyzed using annexin V binding, mitochondrial membrane potential disruption, caspase-3 activation, and cell cycle analysis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371598,1790388140,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":99,"preview_page_count":33,"preview_urls":146},2336475104957,"https://ap-avatar.wpscdn.com/avatar/22000c4c6bd8a5076e1?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787554080175789136","Article  \nPro-Apoptotic Activity of 1-(4,5,6,7-Tetrabromo-1H-benzimidazol-1-yl)propan-2-one, an Intracellular Inhibitor of PIM-1 Kinase in Acute Lymphoblastic Leukemia and Breast Cancer Cells  \nPatrycja Wi ´nska 1,*, Monika Wielechowska 1, Łukasz Milewski 2, Paweł Siedlecki 2  \nand Edyta Łukowska-Chojnacka 1  \nAcademic Editor: Bernhard Biersack  \nReceived: 16 May 2025  \nRevised: 13 June 2025  \nAccepted: 17 June 2025  \nPublished: 19 June 2025  \nCitation: Wi ´nska, P.; Wielechowska, M.; Milewski, Ł.; Siedlecki, P.;  \nŁukowska-Chojnacka, E.  \nPro-Apoptotic Activity of 1-(4,5,6,7-Tetrabromo-1Hbenzimidazol-1-yl)propan-2-one, an Intracellular Inhibitor of PIM-1 Kinasein Acute Lymphoblastic Leukemia and Breast Cancer Cells. Int. J. Mol. Sci. 2025, 26, 5897. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms26125897](10.3390/ijms26125897)  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Faculty of Chemistry, Warsaw University of Technology, Noakowskiego St. 3, 00-664 Warsaw, Poland; [monika.wielechowska@pw.edu.pl](monika.wielechowska@pw.edu.pl) (M.W.); [edyta.chojnacka@pw.edu.pl](edyta.chojnacka@pw.edu.pl) (E.Ł.-C.)  \n2 Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawi ´nskiego St. 5A, 02-106 Warsaw, Poland; [lmilewski@ibb.waw.pl](lmilewski@ibb.waw.pl) (Ł.M.); [pawel@ibb.waw.pl](pawel@ibb.waw.pl) (P.S.)  \n* [Correspondence: patrycja.winska@pw.edu.pl](Correspondence: patrycja.winska@pw.edu.pl); Tel.: +48-222345573  \nAbstract: Inhibition of CK2 and/or PIM-1 kinases has been shown to induce apoptosis in a variety of cancer cell lines, underscoring their potential as valuable targets in anti-cancer drug development. In this study, a series of N-substituted derivatives of 4,5,6,7-tetrabromo- 1H-benzimidazole, including 2-oxopropyl/2-oxobutyl substituents and their respective hydroxyl analogues, were synthesized and evaluated for anti-cancer activity. The compounds’ ability to inhibit CK2α and PIM-1 kinases was assessed through enzymatic assays, complemented by comprehensive in silico enzyme–substrate docking analyses. Cytotoxicity was evaluated using the MTT assay in human cancer cell lines—including acute lymphoblastic leukemia (CCRF-CEM) and breast cancer (MCF-7, MDA-MB-231)—as well as in normal Vero cells. Apoptosis induction in the two most responsive cell lines (CCRFCEM and MCF-7) was further examined using flow cytometry-based assays, including annexin V binding, mitochondrial membrane potential disruption, caspase-3 activation, and cell cycle analysis. Intracellular inhibition of CK2 and PIM-1 kinases was confirmed in CCRF-CEM and MCF-7 cells using Western blot and phospho-flow cytometry. Among the synthesized compounds, we identified a novel TBBi derivative exhibiting pronounced pro-apoptotic activity and the ability to inhibit PIM-1 kinase intracellularly. These findings support the hypothesis that PIM-1 kinase represents a promising molecular target for the treatment of leukemia.  \nKeywords: TBBi derivatives; protein kinase CK2; PIM kinase; anti-tumor activity; leukemia; breast cancer  \n1. Introduction  \nProtein kinases are key mediators of signal transduction pathways, which are frequently dysregulated in cancer, making them among the most promising targets for drug development. Several chemical kinase inhibitors have shown potent clinical activity in tumors in which the target kinase is deregulated, which resulted in the approval of about 80 kinase inhibitors for clinical use in Europe [1] . The constitutively active serine/threonine kinases CK2 and PIM-1 show abnormally high expression levels in many cancers, particularly prostate, breast, and lung cancers, and in hematological cancers [2,3] . ","cbCailofn0LH6BrP","https://ap.wps.com/l/cbCailofn0LH6BrP","pdf",5430348,24,"English","# Abstract\n# Introduction\n## Protein kinases as drug targets\n## CK2 and PIM-1 in cancer biology\n## Rationale for PIM-1 and CK2 inhibition\n# Materials and Methods\n## Enzyme and in silico assessments\n## Cytotoxicity and apoptosis assays\n## Intracellular target validation\n# Results\n## Kinase inhibition and docking outcomes\n## Cytotoxicity in leukemia and breast cancer cells\n## Apoptosis mechanisms and cell cycle effects\n## Identification of a lead TBBi derivative\n# Discussion\n## Implications for leukemia treatment","[{\"question\":\"What was the main goal of this study?\",\"answer\":\"To synthesize N-substituted tetrabromo-benzimidazole derivatives and evaluate whether they can induce apoptosis by inhibiting CK2 and/or PIM-1, including intracellular PIM-1 inhibition.\"},{\"question\":\"How were kinase inhibition and anti-cancer activity assessed?\",\"answer\":\"CK2α and PIM-1 inhibition were measured by enzymatic assays and supported by in silico docking; anti-cancer effects were evaluated using MTT cytotoxicity assays in cancer cell lines.\"},{\"question\":\"Which assays were used to confirm apoptosis induction?\",\"answer\":\"In the most responsive lines (CCRF-CEM and MCF-7), apoptosis was analyzed using annexin V binding, mitochondrial membrane potential disruption, caspase-3 activation, and cell cycle analysis.\"}]","Pro-Apoptotic Activity of 1-(4,5,6,7-Tetrabromo-1H-benzimidazol-1-yl)propan-2-one - an Intracellular Inhibitor of PIM-1 Kinase in Acute Lymphoblastic Leukemia and Breast Cancer Cells | PDF",1790192413,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0fe9e23e4e95043772d5724f25965277.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/534242cb6426baaa87d1cb662ab6ca54.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8cae7354d717ac45a40d15e31a45a8d0.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/968a35842688ea775c3453f29ab74188.webp",980,1385]